Elelyso
| Chemical Name | taliglucerase alfa |
| Dosage Form | Injection (intravenous; 200 units/vial) |
| Drug Class | Enzymes |
| System | Blood |
| Company | Pfizer Inc. |
| Approval Year | 2012 |
Indication
- For the treatment of type 1 gaucher disease in patients 4 years and older with a confirmed diagnosis.